ANALYSIS OF mRNA TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA PATIENTS

We measured circulating endothelial precursor cells (EPCs), activated circulating endothelial cells (aCECs), and mature circulating endothelial cells (mCECs) using

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase – the importance of a major molecular response1. Medical

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month

The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response

Na realização do Laboratório, manteve-se a situação de aprendizagem “Aplicação do conhecimento matemático na organização do planejamento financeiro de uma empresa”,

Multiple BCR-ABL kinase domain mutations confer polyclonal resis- tance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid

O objetivo deste trabalho é relatar o caso clínico de transplante dentário autógeno, realizado em sessão única, como alternativa terapêutica aos demais métodos